Canary Wharf Group (CWG) and Kadans Science Partner (Kadans) have announced a joint venture to develop a new wet lab enabled building at Canary Wharf in London.

The development will be the first phase in the creation of a world leading centre for health and life sciences on the 3.3-hectare North Quay site next to the new Elizabeth line station.

The project brings together two market leaders with highly complementary skills and resources. CWG's construction, development and placemaking experience is matched by Kadans' expertise as a European leader in the development and management of life sciences buildings and ecosystems.


With 750,000 sq ft of space across 22 storeys, the building, which will be delivered in 2026, will be the largest commercial wet lab enabled life science building in Europe. Importantly it will be a laboratory building at its core, with full flexibility allowing lab space on all floors.

Designed by KPF and developed to the highest sustainability and technological standards, the building will leverage Kadans' experience of curating multi-let lab and office projects with vibrant communities. The building will create a campus under one roof, housing SME’s and academics as well as global healthcare and pharmaceutical companies.

Shobi Khan, CEO Canary Wharf Group, said: "Canary Wharf Group has been developing a vision for health and life sciences since 2019 and we are proud to be working with an exceptional partner in Kadans, the European leader in the development and management of life sciences buildings and ecosystems.

"We are creating a world class building that will provide state of the art laboratory, office and innovation space for some of the most exciting and fast-growing businesses in the health and life sciences sector."